THE GRUNENTHAL GROUP
The Grunenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation. Grunenthal is one of the last five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Researc... h and development costs amounted to about 27 percent of revenues in 2013. Grunenthal's research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. They are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies. Altogether, the Grunenthal Group has affiliates in 25 countries worldwide. Grünenthal products are sold in more than 155 countries and approx. 5,500 employees are working for the Grünenthal Group worldwide. In 2013, Grünenthal achieved revenues of €901 mn.
THE GRUNENTHAL GROUP
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
1946-01-01
Address:
Aachen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.grunenthal.com
Total Employee:
5001+
Status:
Active
Contact:
(241) 569-0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Takeda Oncology
Takeda Oncology is a leading biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-12 | Mestex | Mestex acquired by The Grunenthal Group | N/A |
| 2018-11-14 | Averitas Pharma | Averitas Pharma acquired by The Grunenthal Group | N/A |
| 2017-04-07 | Adhesys Medical | Adhesys Medical acquired by The Grunenthal Group | N/A |
Newest Events participated
Official Site Inspections
http://www.grunenthal.com Semrush global rank: 1.13 M Semrush visits lastest month: 28.49 K
- Host name: 20.50.2.24
- IP address: 20.50.2.24
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "The Grunenthal Group"
Welcome | Grunenthal
Grünenthal is a global leader in pain management and related diseases.See details»
Company | Grünenthal
Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high …See details»
Grünenthal - Wikipedia
Grünenthal Company Overview
Our virtual company showcase provides information about our key objectives and activities, recent business development highlights, and financial performance.See details»
Company Overview | About us | Grünenthal Ltd
Grünenthal is an independent, family-owned integrated research and development company with more than 50 years of experience in pain research.See details»
Grünenthal Group - The Org
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to …See details»
Grünenthal - Crunchbase Company Profile & Funding
Headquarters Regions, Founded Date 1946 Operating Status Active Legal Name Laboratoires Grünenthal SAS Company Type For Profit Contact Email [email protected] Phone …See details»
The Grunenthal Group - Crunchbase Company Profile …
The Grunenthal Group is a pharmaceutical company that offers R&D and treatments for pain management and related diseases.See details»
Org Chart Grunenthal - The Official Board
The org chart of Grunenthal contains its 25 main executives including Gabriel Baertschi and Fabian Raschke.See details»
Global presence & sites | About us | Grünenthal
Although firmly rooted in Germany, today we’re very much a growing global business, represented in 27 countries and maintaining production sites in five.See details»
Grunenthal - Crunchbase Company Profile & Funding
Grunenthal is a pharmaceutical company that specializes in pain management and related diseases.See details»
Global Capabilities | About us | Grünenthal Ltd
Although firmly rooted in Germany, today we’re very much a growing global business, represented in 29 countries and maintaining production sites in six.See details»
Our culture - Grünenthal
At Grünenthal, entrepreneurial spirit means challenging the status quo, trying new things and taking smart risks. We think and act strategically, identify trends, plan for the long-term and …See details»
75 years of Grünenthal
CEO Grünenthal This year, Grünenthal celebrates 75 years of developing breakthrough medicines for patients around the world. For us, it is a time to take stock of everything we have …See details»
Grünenthal Company Profile | Management and Employees List
Find contact information for Grünenthal. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Grünenthal's email format.See details»
Careers | Grünenthal
At Grünenthal, we join forces to make an impact. We are a mid-sized, innovation-driven company with a strong international footprint that offers excellent working conditions and great career …See details»
Procurement and Supply Chain Management - The Org
The Procurement and Supply Chain Management team at Grünenthal Group is responsible for sourcing and managing the materials and services essential to the development and …See details»
Grunenthal Group | World Pharma Today
Grunenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, …See details»
Science | Grünenthal
Grünenthal’s research & development pipeline and external innovation.See details»
The role of the immune system in osteoarthritis: mechanisms
Mar 13, 2025 This Review provides an update on the role of innate and adaptive immune cells in the pathogenesis of osteoarthritis. The authors discuss emerging therapeutics that target the …See details»